Company intelligence / Profile preview

Pomerantz

Ownership: Private
Development stage: Other

Overview

Pomerantz is one of the world’s oldest and most prominent plaintiff-side law firms specializing in securities class actions and investor rights. Founded in 1936, the firm has played a pioneering role in representing defrauded investors across industries—including biotech, pharma, and healthcare—by litigating high-profile cases against public companies for alleged misstatements or fraud. Notable settlements include $3 billion with Petrobras and significant wins involving companies like Wynn Resorts, Amazon.com, Altria/JUUL, Deutsche Bank, Arconic Inc., Perrigo Co., Bausch Health Companies/Bausch + Lomb Corporation, Canopy Growth Corporation, Danaher Corporation, ImmunityBio Inc., and several biotechnology firms. The firm frequently acts as lead or co-lead counsel in major class actions.

Industry: Consulting

Beyond the preview

Go deeper on Pomerantz.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pomerantz.

Explore the full profile